Home
About
Overview
Sharing Data
ORCID
Help
History (51)
LNK deficiency promotes acute aortic dissection and rupture.
Phase II trial of sequential bevacizumab (B), erlotinib (E) and chemotherapy for first line treatment of clinical stage IIIB or IV non-small cell lung cancer (NSCLC).
Oxamflatin treatment enhances cloned porcine embryo development and nuclear reprogramming.
Efficiency of colorectal cancer care among veterans: analysis of treatment wait times at Veterans Affairs Medical Centers.
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.
See All 51 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer. N Engl J Med. 2018 Jul 12; 379(2):122-137.
View in:
PubMed
subject areas
Adult
Androstadienes
Antineoplastic Agents, Hormonal
Aromatase Inhibitors
Breast Neoplasms
Chemotherapy, Adjuvant
Disease-Free Survival
Female
Follow-Up Studies
Humans
Kaplan-Meier Estimate
Middle Aged
Neoplasm Recurrence, Local
Premenopause
Receptor, ErbB-2
Tamoxifen
Young Adult
authors with profiles
Gini Fleming